|
Date |
Time |
Lecture |
Faculty |
Tuesday
8/23/2011 |
12:30pm - 2:30pm |
Course Overview & Objectives
The Drug Discovery, Development & Approval Process
Historical Perspectives: The Legacy of the Past and the Evolution of Drug Discovery & Modern Medicine |
Barrett
Clark |
Thursday
8/25/2011 |
12:30pm - 2:30pm |
Drug Research Strategy: Organizational Aspects of the Pharmaceutical Industry and Addressing Unmet Medical Needs
Central Nervous System Drug Discovery |
Williams |
Tuesday
8/30/2011 |
12:30pm - 2:30pm |
Target Based Drug Discovery: Diversity of Targets, Identification, Selection and Validation |
Ring |
Thursday
9/1/2011 |
NO CLASSES |
Tuesday
9/6/2011 |
12:30pm - 2:30pm |
High Throughput Screening: Sample Libraries, Hit Identification
Lead Identification & Lead Optimization |
Bednar
Murphy |
Thursday
9/8/2011 |
12:30pm - 2:30pm |
Computational Modeling
Chemical and Biological Space: Medicinal Chemistry and Structure-Activity Relationships |
Kortagere
Adejare |
Tuesday
9/13/2011 |
12:30pm - 2:30pm |
Preclinical Assessment I: In Vivo Model Systems
Predictive Utility of Animal Models |
McGonigle
Rosenzweig-Lipson |
Thursday
9/15/2011 |
12:30pm - 2:30pm |
Case Study in Drug Discovery and Development I: Modafinil |
Vaught |
Tuesday
9/20/2011 |
12:30pm - 2:30pm |
Preclinical Assessment II: Safety and Toxicology
Biologics |
Derelanko
Chen |
Thursday
9/22/2011 |
12:30pm - 2:30pm
|
Clinical Trial Design
Bioinformatics in Drug Discovery & Development |
Voralu
Gipson |
Tuesday
9/27/2011 |
12:30pm - 2:30pm |
Clinical Research I: Phase I Studies First in Humans: Safety & Tolerability |
Paul |
Thursday
9/29/2011 |
12:30pm - 2:30pm |
Biologics |
Chen |
Tuesday
10/4/2011 |
12:30pm - 2:30pm |
Clinical Research II: Phase II Studies & Clinical Trial Designs |
Block |
Thursday
10/6/2011 |
NO CLASS - DISCOVERY DAY |
Tuesday
10/11/2011 |
12:30pm - 2:30pm |
Current Status & Emerging Trends in the Pharmaceutical & Biotechnology Industry |
Hargreaves |
Thursday
10/13/2011 |
12:30pm - 2:30pm |
Clinical Research III: Phase III Studies: Safety and Efficacy |
Mangano |
Tuesday
10/18/2011 |
12:30pm - 2:30pm |
Therapeutic Treatment & Unmet Needs I: Oncology |
Frost |
|
Thursday
10/20/2011
|
12:30pm - 2:30pm |
Overview of Pharmacogenetics: Personalized Medicine
Bioinformatics |
Stone
Gipson |
Tuesday
10/25/2011 |
12:30pm - 2:30pm |
In Vivo Antinfective Drug Screening and Evaluation
Patent Law in the Pharmaceutical Industry |
Khan
Blass |
Thursday
10/27/2011 |
12:30pm - 2:30pm |
Translational & Experimental Medicine: Use of Pharmacodynamic Markers & Biomarkers in Drug Discovery & Development |
Potter |
Tuesday
11/1/2011 |
12:30pm - 2:30pm |
Project Team Formation: Mock Discovery and Development Project |
Antal |
Thursday
11/3/2011 |
12:30pm - 2:30pm |
Beyond Small Molecules: RNAi Therapeutics
Vaccines |
Lubbers
Kutzler |
Tuesday
11/8/2011 |
12:30pm - 2:30pm |
The FDA: Regulatory Guidelines and Drug Development: History and Current Status
Post-marketing Surveillance |
Basseches
Killion |
Thursday
11/10/2011 |
12:30pm - 2:30pm |
Case Study in Drug Discovery and Development II: Carvedilol for the Treatment of Heart Failure |
Ohlstein |
Tuesday
11/15/2011 |
12:30pm - 2:30pm |
Overview of Commercial and Marketing |
Cannon |
Thursday
11/17/2011 |
12:30pm - 2:30pm |
SPECIAL CLASS: Project Team Presentations
(Room 8312 - NCB) |
Antal |
Monday
11/21/11 |
12:30pm - 2:30pm |
Case Study in Drug Discovery and Development III: Januvia
(Room 8312 - NCB)
|
hornberry |
Tuesday
11/22/2011 |
12:30pm - 2:30pm |
Case Study in Drug Discovery and Development IV: Entereg. for the Treatment of Postoperative Ileus |
Techner |
Thursday
11/24/2011 |
12:30pm - 2:30pm |
Current Status and Future Trends in the Pharmaceutical Industry
Round Table Discussion
(Room - 8312 - NCB) |
Barrett
Clark |